The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Prostate-Specific Antigen (PSA) Test-Global Market Insights and Sales Trends 2025
Synopsis
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.
The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood.
The global Prostate-Specific Antigen (PSA) Test market size is expected to reach US$ 628.6 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Prostate-Specific Antigen (PSA) Test in various end use industries. The expanding demands from the Screening, Post-treatment Monitoring and Other, are propelling Prostate-Specific Antigen (PSA) Test market. CLIA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the ELISA segment is estimated at % CAGR for the next seven-year period.
The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 80% of the global market. CLIA is the main type, with a share over 70%. Screening is the key application, which holds a share about 80%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prostate-Specific Antigen (PSA) Test, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prostate-Specific Antigen (PSA) Test market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prostate-Specific Antigen (PSA) Test market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prostate-Specific Antigen (PSA) Test sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prostate-Specific Antigen (PSA) Test covered in this report include Abbott, Siemens Healthcare, DiaSorin, Roche, Beckman Coulter, PerkinElmer, Tosoh, Ortho Clinical and Fujirebio, etc.
The global Prostate-Specific Antigen (PSA) Test market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch (LABORIE)
BodiTech
Global Prostate-Specific Antigen (PSA) Test market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prostate-Specific Antigen (PSA) Test market, Segment by Type:
CLIA
ELISA
Other
Global Prostate-Specific Antigen (PSA) Test market, by Application
Screening
Post-treatment Monitoring
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Prostate-Specific Antigen (PSA) Test companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.
The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood.
The global Prostate-Specific Antigen (PSA) Test market size is expected to reach US$ 628.6 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Prostate-Specific Antigen (PSA) Test in various end use industries. The expanding demands from the Screening, Post-treatment Monitoring and Other, are propelling Prostate-Specific Antigen (PSA) Test market. CLIA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the ELISA segment is estimated at % CAGR for the next seven-year period.
The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 80% of the global market. CLIA is the main type, with a share over 70%. Screening is the key application, which holds a share about 80%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prostate-Specific Antigen (PSA) Test, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prostate-Specific Antigen (PSA) Test market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prostate-Specific Antigen (PSA) Test market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prostate-Specific Antigen (PSA) Test sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prostate-Specific Antigen (PSA) Test covered in this report include Abbott, Siemens Healthcare, DiaSorin, Roche, Beckman Coulter, PerkinElmer, Tosoh, Ortho Clinical and Fujirebio, etc.
The global Prostate-Specific Antigen (PSA) Test market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch (LABORIE)
BodiTech
Global Prostate-Specific Antigen (PSA) Test market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prostate-Specific Antigen (PSA) Test market, Segment by Type:
CLIA
ELISA
Other
Global Prostate-Specific Antigen (PSA) Test market, by Application
Screening
Post-treatment Monitoring
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Prostate-Specific Antigen (PSA) Test companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Prostate-Specific Antigen (PSA) Test
1.1 Prostate-Specific Antigen (PSA) Test Market Overview
1.1.1 Prostate-Specific Antigen (PSA) Test Product Scope
1.1.2 Prostate-Specific Antigen (PSA) Test Market Status and Outlook
1.2 Global Prostate-Specific Antigen (PSA) Test Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Prostate-Specific Antigen (PSA) Test Market Size by Region (2018-2029)
1.4 Global Prostate-Specific Antigen (PSA) Test Historic Market Size by Region (2018-2023)
1.5 Global Prostate-Specific Antigen (PSA) Test Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Prostate-Specific Antigen (PSA) Test Market Size (2018-2029)
1.6.1 North America Prostate-Specific Antigen (PSA) Test Market Size (2018-2029)
1.6.2 Europe Prostate-Specific Antigen (PSA) Test Market Size (2018-2029)
1.6.3 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size (2018-2029)
1.6.4 Latin America Prostate-Specific Antigen (PSA) Test Market Size (2018-2029)
1.6.5 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size (2018-2029)
2 Prostate-Specific Antigen (PSA) Test Market by Type
2.1 Introduction
2.1.1 CLIA
2.1.2 ELISA
2.1.3 Other
2.2 Global Prostate-Specific Antigen (PSA) Test Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Prostate-Specific Antigen (PSA) Test Historic Market Size by Type (2018-2023)
2.2.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Prostate-Specific Antigen (PSA) Test Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Prostate-Specific Antigen (PSA) Test Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Prostate-Specific Antigen (PSA) Test Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Prostate-Specific Antigen (PSA) Test Revenue Breakdown by Type (2018-2029)
3 Prostate-Specific Antigen (PSA) Test Market Overview by Application
3.1 Introduction
3.1.1 Screening
3.1.2 Post-treatment Monitoring
3.1.3 Other
3.2 Global Prostate-Specific Antigen (PSA) Test Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Prostate-Specific Antigen (PSA) Test Historic Market Size by Application (2018-2023)
3.2.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Prostate-Specific Antigen (PSA) Test Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Prostate-Specific Antigen (PSA) Test Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Prostate-Specific Antigen (PSA) Test Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Prostate-Specific Antigen (PSA) Test Revenue Breakdown by Application (2018-2029)
4 Prostate-Specific Antigen (PSA) Test Competition Analysis by Players
4.1 Global Prostate-Specific Antigen (PSA) Test Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostate-Specific Antigen (PSA) Test as of 2022)
4.3 Date of Key Players Enter into Prostate-Specific Antigen (PSA) Test Market
4.4 Global Top Players Prostate-Specific Antigen (PSA) Test Headquarters and Area Served
4.5 Key Players Prostate-Specific Antigen (PSA) Test Product Solution and Service
4.6 Competitive Status
4.6.1 Prostate-Specific Antigen (PSA) Test Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
5.1.4 Abbott Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 Siemens Healthcare
5.2.1 Siemens Healthcare Profile
5.2.2 Siemens Healthcare Main Business
5.2.3 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
5.2.4 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2018-2023)
5.2.5 Siemens Healthcare Recent Developments
5.3 DiaSorin
5.3.1 DiaSorin Profile
5.3.2 DiaSorin Main Business
5.3.3 DiaSorin Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
5.3.4 DiaSorin Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Recent Developments
5.4 Roche
5.4.1 Roche Profile
5.4.2 Roche Main Business
5.4.3 Roche Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
5.4.4 Roche Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Recent Developments
5.5 Beckman Coulter
5.5.1 Beckman Coulter Profile
5.5.2 Beckman Coulter Main Business
5.5.3 Beckman Coulter Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
5.5.4 Beckman Coulter Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2018-2023)
5.5.5 Beckman Coulter Recent Developments
5.6 PerkinElmer
5.6.1 PerkinElmer Profile
5.6.2 PerkinElmer Main Business
5.6.3 PerkinElmer Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
5.6.4 PerkinElmer Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2018-2023)
5.6.5 PerkinElmer Recent Developments
5.7 Tosoh
5.7.1 Tosoh Profile
5.7.2 Tosoh Main Business
5.7.3 Tosoh Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
5.7.4 Tosoh Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2018-2023)
5.7.5 Tosoh Recent Developments
5.8 Ortho Clinical
5.8.1 Ortho Clinical Profile
5.8.2 Ortho Clinical Main Business
5.8.3 Ortho Clinical Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
5.8.4 Ortho Clinical Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2018-2023)
5.8.5 Ortho Clinical Recent Developments
5.9 Fujirebio
5.9.1 Fujirebio Profile
5.9.2 Fujirebio Main Business
5.9.3 Fujirebio Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
5.9.4 Fujirebio Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2018-2023)
5.9.5 Fujirebio Recent Developments
5.10 Mediwatch (LABORIE)
5.10.1 Mediwatch (LABORIE) Profile
5.10.2 Mediwatch (LABORIE) Main Business
5.10.3 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
5.10.4 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2018-2023)
5.10.5 Mediwatch (LABORIE) Recent Developments
5.11 BodiTech
5.11.1 BodiTech Profile
5.11.2 BodiTech Main Business
5.11.3 BodiTech Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
5.11.4 BodiTech Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2018-2023)
5.11.5 BodiTech Recent Developments
6 North America
6.1 North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Prostate-Specific Antigen (PSA) Test Market Dynamics
11.1 Prostate-Specific Antigen (PSA) Test Industry Trends
11.2 Prostate-Specific Antigen (PSA) Test Market Drivers
11.3 Prostate-Specific Antigen (PSA) Test Market Challenges
11.4 Prostate-Specific Antigen (PSA) Test Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
